A novel chemokine‐based signature for prediction of prognosis and therapeutic response in gliomaWenhua Fan, Ying Zhang, Jianbao Xu et al.|CNS Neuroscience & Therapeutics|2022Cited by 36
WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous SystemZheng Zhao, Tao Jiang, Kenan Zhang et al.|Scientific Data|2022Cited by 17
Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort PatientsZenghui Qian, Zheng Zhao, Wenhua Fan et al.|Frontiers in Cell and Developmental Biology|2021Cited by 15
MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitorsKenan Zhang, Tao Jiang, Zheng Zhao et al.|Holistic Integrative Oncology|2022Cited by 5
Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse gliomaJing Feng, Xiaolong Fan, Zheng Zhao et al.|Frontiers of Medicine|2023Cited by 4